Holen Sie sich die Stockscreener-App
9.08
6.39%
-0.62
Handel nachbörslich:
9.05
-0.03
-0.33%
Kura Oncology Inc Aktie (KURA) Neueste Nachrichten
Caspian Therapeutics and Kura Oncology Outline KO-7246 Development Strategy in Diabetes - GlobeNewswire
Caspian Therapeutics and Kura Oncology to host investor call By Investing.com - Investing.com
Caspian Therapeutics and Kura Oncology to Host Investor Webcast on Caspian Formation and KO-7246 Data from EASD Meeting - Quiver Quantitative
Caspian Therapeutics and Kura Oncology to Host Investor - GlobeNewswire
Kura Oncology (KURA) Stock Price, News & Analysis - Stock Titan
Kura Oncology Share PriceKURA, RNS News, Articles, Quotes, & Charts (NASDAQ:KURA) - Proactive financial news
Why Is KURA Stock Rallying 8% After-Hours? - Stocktwits
Kura Oncology Inc. Company & People | KUR - Barron's
Nine new hires get rights to buy 128,250 Kura shares, phased in over four years. - Stock Titan
Kura Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewswire
Kura Oncology, Inc. : JP Morgan Initiates Cov - Moomoo
Kura Oncology, Inc. (KURA) stock price, news, quote and history - uk.finance.yahoo.com
Kura Oncology, Inc. (KURA) Stock Price, News, Quote & History - Yahoo! Finance Canada
Kura Oncology CCO Brian Powl sells over $345k in company stock - Investing.com
Kura Oncology SVP sells $48,360 of stock - Investing.com
Kura Oncology COO Kathleen Ford sells $111,930 in company stock - Investing.com
A tax-related sale followed stock vesting: Kura Oncology (KURA) executive sold 4,607 shares. - Stock Titan
One sale covered taxes; two followed a trading plan. Kura Oncology (KURA) executive sold 32,450 shares. - Stock Titan
Return on equity % of Kura Oncology, Inc. – HAN:KUR - TradingView
Kura Oncology, Inc. Earnings and Revenue – HAN:KUR - TradingView
Kura Oncology, Inc. Revenue Breakdown – HAN:KUR - TradingView
ETFs Investing in Kura Oncology, Inc. Stocks - TradingView
Kura Oncology, Inc. Earnings and Revenue – HAN:KUR - TradingView
After three earlier sales, a Kura Oncology (KURA) officer proposes another share sale - Stock Titan
After selling 12,448 shares, a Kura Oncology (KURA) officer proposes selling 28,802 more. - Stock Titan
Shares valued at $74,308.56 are proposed for sale by Kura Oncology (KURA) officer Kathleen Ford. - Stock Titan
An August sale of 31,487 stock units precedes another proposed sale by Kura Oncology (KURA) officer Teresa Bair. - Stock Titan
A planned $133,940 share sale at Kura Oncology (KURA) involves officer Mollie Leoni. - Stock Titan
Shares valued at $49,571 are in a proposed sale by Kura Oncology (KURA) officer Thomas James Doyle. - Stock Titan
Two sales, two reasons: Kura Oncology (KURA) medical chief sold shares to cover taxes and under a trading plan. - Stock Titan
A stock award triggers a tax-covering share sale by Kura Oncology (KURA) COO Kathleen Ford. - Stock Titan
A tax-related sale leaves Kura Oncology (KURA) legal chief with 187,002 shares. - Stock Titan
Form 144 KURA ONCOLOGY For: 25 September By Investing.com - Investing.com Canada
Shares from a stock option exercise are proposed for sale by a Kura Oncology (KURA) officer, valued at $224,514. - Stock Titan
Kura Oncology, Inc. (KURA) Stock Analysis: A Biotech Innovator with a 173% Potential Upside - DirectorsTalk Interviews
Kura Oncology (KURA) awards CFO 450,000 stock options - Stock Titan
Kura Oncology (KURA) CFO files initial ownership report with no trades - Stock Titan
Kura Oncology Maintains 49.2% Stake in Caspian Therapeutics Following $50M Series A Funding - Kalkine Media
Kura Spins Out Caspian With $50m To Test Menin Inhibition In Diabetes - insights.citeline.com
Kura assets flow to Caspian for cardiometabolic indications - BioWorld News
Kura Oncology Pivots Diabetes Strategy Into $50 Million Subsidiary - AOL.com
Kura Oncology Raises $50M for Cardiometabolic Subsidiary Caspian - minichart.com.sg
KURA Oncology Launches Caspian Therapeutics, Shifting Focus Whil - GuruFocus
Kura Oncology at cantor conference: rapid launch, wider ambitions - Investing.com India
Kura Oncology Pivots Diabetes Strategy Into $50 Million Subsidiary - Yahoo Finance
Kura Oncology, Inc. Enters into Contribution and License and Intercompany Services Agreement with Caspian Therapeutics, Inc - marketscreener.com
Kura Oncology Launches Caspian Therapeutics With $50 Million Funding - marketscreener.com
Kura Oncology Appoints Jennifer Fulk as New CFO - The Globe and Mail
Kura Oncology Establishes Caspian Partnership for Cardiometabolic Focus - TipRanks
Kura Oncology Launches Caspian Therapeutics with $50 Million Financing to Advance Menin Inhibition as a Potential Disease-Modifying Approach for Diabetes - The Manila Times
6.92%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):